Rare diseases
Investigational molecules
Locations
Back to Germany111 clinical trials in Bad Bentheim, Germany across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)A Study of KT-621 Tablets Taken by Mouth for Adults with Moderate to Severe Atopic Dermatitis
GermanyA study testing BFB759 compared to placebo to evaluate effectiveness and safety in adult patients with atopic dermatitis
GermanyStudy of zasocitinib (TAK-279) and apremilast compared to placebo in adults with moderate to severe plaque psoriasis
GermanyStudy of Rocatinlimab Treatment for Adults and Adolescents with Moderate to Severe Atopic Dermatitis
GermanyStudy of rocatinlimab (AMG 451) in adolescents with moderate to severe atopic dermatitis to evaluate its effectiveness and safety over 52 weeks
GermanyLong-term safety and effectiveness study of sonelokimab injections for patients with moderate to severe hidradenitis suppurativa
GermanyStudy of Ruxolitinib Cream for Children and Adolescents Ages 6-17 with Moderate Atopic Dermatitis Who Did Not Respond Well to Standard Treatments
GermanyStudy on Rocatinlimab for Adults with Moderate-to-Severe Atopic Dermatitis
GermanyStudy on the Effectiveness and Safety of Remibrutinib for Adults with Moderate to Severe Hidradenitis Suppurativa
GermanyStudy on the Effectiveness and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on Long-term Safety and Effectiveness of ESK-001 for Patients with Moderate to Severe Plaque Psoriasis
GermanyStudy on the Effectiveness and Safety of JNJ-95475939 and Dupilumab for Treating Moderate to Severe Atopic Dermatitis in Adults
GermanyThe busiest research cities in the country
What the registry says about research in the country
Several groundbreaking trials focusing on plaque psoriasis and psoriatic arthritis are evaluating novel therapeutic approaches. Research includes comparative studies of new biological treatments and long-term safety assessments.
These studies aim to improve treatment outcomes for patients with varying severities of psoriatic conditions.
Innovative clinical trials are investigating treatments for atopic dermatitis and chronic hand eczema. Studies range from evaluating new biological therapies to investigating dose optimization strategies.
Research focuses on both adult and adolescent populations, with emphasis on long-term efficacy and safety.
Research initiatives addressing various dermatological conditions, including hidradenitis suppurativa, prurigo nodularis, and actinic keratosis. Novel therapeutic approaches are being tested.
These trials aim to develop targeted treatments for challenging skin conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
